Achieve life sciences to announce third quarter financial results and host conference call and webcast on november 6, 2025

Seattle and vancouver, british columbia, oct. 29, 2025 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its third quarter 2025 financial results and provide a corporate update on the cytisinicline development program on thursday, november 6, 2025, at 8:30 am est.
ACHV Ratings Summary
ACHV Quant Ranking